{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:15:10Z","timestamp":1748909710703},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,6,15]]},"DOI":"10.2169\/internalmedicine.5783-20","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T22:13:10Z","timestamp":1610662390000},"page":"1835-1838","source":"Crossref","is-referenced-by-count":1,"title":["Peg-IFN\u03b1-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up"],"prefix":"10.2169","volume":"60","author":[{"given":"Tomoko","family":"Tadokoro","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Oura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asahiro","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Yoneyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Himoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University School of Medicine\/Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"1. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73, 2006.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"2","unstructured":"3. Sakamoto K, Beppu T, Hayashi H, et al. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort. Anticancer Res 35: 1647-1655, 2015."},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Zhou Y, Zhang Z, Zhao Y, et al. Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis. World J Surg 38: 2395-2402, 2014.","DOI":"10.1007\/s00268-014-2586-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5. Liu GM, Huang XY, Shen SL, et al. Adjuvant antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after curative treatment: A systematic review and meta-analysis. Hepatol Res 46: 100-110, 2016.","DOI":"10.1111\/hepr.12584"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6. Yin J, Li N, Han Y, et al. Effect of antiviral treatment with nucleotide\/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study. J Clin Oncol 31: 3647-3655, 2013.","DOI":"10.1200\/JCO.2012.48.5896"},{"key":"6","doi-asserted-by":"publisher","unstructured":"7. Tseng TC, Liu CJ, Yang HC, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 142: 1140-1149, 2012.","DOI":"10.1053\/j.gastro.2012.02.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. JSH Guidelines for the Management of Hepatitis B Virus Infection Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology. Hepatol Res 44 (Suppl): 1-58, 2014.","DOI":"10.1111\/hepr.12269"},{"key":"8","doi-asserted-by":"publisher","unstructured":"9. Yuen MF, Wong DK, Fung J, et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 135: 1192-1199, 2008.","DOI":"10.1053\/j.gastro.2008.07.008"},{"key":"9","doi-asserted-by":"publisher","unstructured":"10. Simonetti J, Bulkow L, McMahon BJ, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 51: 1531-1537, 2010.","DOI":"10.1002\/hep.23464"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Giannakopoulos NV, Luo JK, Papov V, et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. BiochemBiophys Res Commun 336: 496-506, 2005.","DOI":"10.1016\/j.bbrc.2005.08.132"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 6: 112-119, 1996.","DOI":"10.1016\/S0928-4346(96)00325-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Brunetto MR, Moriconi F, Bonino F, et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 49: 1141-1150, 2009.","DOI":"10.1002\/hep.22760"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Piratvisuth T, Marcellin P, Popescu M, et al. Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients. Hepatol Int 7: 429-436, 2013.","DOI":"10.1007\/s12072-011-9280-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Fujita K, Mimura S, Iwama H, et al. Serum miRNAs predicting sustained HBs antigen reduction 48 weeks after pegylated interferon therapy in HBe antigen-negative patients. Int J Mol Sci 19: 1940, 2018.","DOI":"10.3390\/ijms19071940"},{"key":"15","doi-asserted-by":"publisher","unstructured":"16. Murata K, Asano M, Matsumoto A, et al. Induction of IFN-\u03bb3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut 67: 362-371, 2016.","DOI":"10.1136\/gutjnl-2016-312653"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_5783-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:31:59Z","timestamp":1624073519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_5783-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5783-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}